Lanxess Q2 2026 Results Overview
Lanxess AG (ETR:LXSG) announced its financial results for the quarter ended 30 June 2026, reporting a net loss of €53 million, compared with a loss of €45 million in the same quarter a year earlier. This loss was materially wider than the €19.9 million loss forecast by the S&P Global Visible Alpha consensus.
Revenue increased 6.5% year‑over‑year to €1.56 billion, surpassing analysts’ expectations of roughly €1.58 billion. The growth was attributed to higher selling prices and stronger volumes, which more than offset adverse currency effects.
Segment Performance
- Specialty Additives: EBITDA before exceptional items rose 33% to €77 million, making it the standout performer for the quarter.
- Consumer Protection and Advanced Intermediates: Both segments posted weaker earnings as higher raw‑material and energy costs neutralised the benefit of price increases.
Cost and Market Pressures
Restructuring expenses, negative currency movements, intensified competitive pressure from Asian peers, and weak demand in the agrochemicals market continued to weigh on overall profitability.
Outlook and Guidance
Lanxess reiterated its fiscal‑year‑2026 guidance, maintaining expectations for EBITDA before exceptional items between €450 million and €550 million. The company emphasized that ongoing restructuring and cost‑cutting initiatives are aimed at strengthening profitability and reducing the group’s dependence on the under‑performing agrochemicals segment.